New ‘dream' daily weight loss pill ‘better than surgery OR fat jabs' and has ‘minimal to no side effects'
Click to share on Facebook (Opens in new window)
A DAILY weight loss pill is a safer alternative to gastric bypass surgery, makers say.
The tablet does the same job by making people feel full for longer.
Sign up for Scottish Sun
newsletter
Sign up
1
A daily weight loss pill, the Synt-101 pill, is a safer alternative to gastric bypass surgery, makers say
Credit: Getty
Its developers say the treatment is a better way to lose weight than surgery or fat jabs, which can trigger severe side-effects.
A pilot human trial on nine patients indicated the pill was safe to use and reduced hunger signals.
It contains a chemical called polydopamine that reacts with an enzyme in the gut to create a lining which moves digestion to an area where fullness hormones are triggered.
The mucosal membrane is then naturally excreted by the body each day. Gastric bypass surgery disconnects the stomach from the small intestine and reattaches it lower down to achieve the same effect.
It is effective but only a few thousand patients have the operation each year on the NHS.
The Synt-101 pill was developed by US company Syntis Bio.
Chief executive Rahul Dhanda told the European Congress on Obesity in Spain: 'The dream is to have this be the go-to drug for weight management.
'The obvious benefit over gastric bypass surgery is you could avoid an invasive procedure and take a daily pill instead.
"Plus a gastric bypass is irreversible whereas you can stop this when you no longer want it.
'This integrates with the mucosal membrane which is naturally excreted by the body. You take the pill once a day in the morning and it should be cleared by the next day.'
40 Day Health Challenge pro reveals top tips to avoid snacking
Mr Dhanda said the pill could also be taken by patients who have come off GLP-1 weight loss injections, such as Wegovy and Mounjaro.
He said: 'The problem with GLP-1s is they are not very tolerable.
'An oral pill is the rational choice because it's simple, tolerable and safe.
'I anticipate the side-effects to be minimal to none.'
'Golden age' for fat fight
A GOLDEN age of obesity treatment is on the horizon with more than 150 new drugs in clinical trials, experts say.
But they need to be rolled out quicker to the 16million fat people in Britain, they believe.
The European Congress on Obesity heard pharma companies are spending billions targeting hunger hormones.
Dr Louis Aronne, of Weill Cornell Medicine in New York, said: 'I call this the golden age of obesity treatment.'
It could take the NHS 12 years to supply all those who need them.
Prof Jason Halford, of the European Association for the Study of Obesity, said: 'These drugs have the potential to help millions.
'If the Government and NHS are serious about prevention, they need to reconsider the speed of the rollout of these drugs.'
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
7 minutes ago
- The Independent
Concerns raised about patient safety ahead of resident doctor walkouts
Changes to the way hospitals will work during resident doctor strikes could 'risk patient safety', the British Medical Association (BMA) has said. A five-day walkout is scheduled to start on Friday and could cause significant upheaval to the NHS in England. It is hoped the strikes could be averted by ongoing talks between the Government and the Resident Doctors Committee (RDC) of the BMA. But with just days before the strikes are due to start, the union has criticised the way the health service is preparing. In previous walkouts, urgent and emergency services have been staffed by senior hospital doctors, including consultants, and pre-planned work was largely postponed. But the BMA said that hospital leaders have been told to continue with scheduled non-urgent care during the fresh bout of strike action. The union said this approach would put patients at risk. Speaking earlier this month, NHS England boss Sir Jim Mackey said 'we can't allow this to play out in a way that it did last time'. The last round of strikes, which also included walkouts by other health workers, came at an estimated cost of £1.5 billion to the NHS in England. Some 1.5 million appointments, procedures and operations were postponed as a result of the stoppages. In a letter to Sir Jim, BMA council chairman Dr Tom Dolphin and deputy council chairwoman Dr Emma Runswick wrote: 'Your decision to instruct hospitals to run non-urgent planned care stretches safe staffing far too thinly, and risks not only patient safety in urgent and emergency situations, but in planned care too. ' Consultants cannot safely provide elective care and cover for residents at the same time. 'We therefore strongly urge you to reconsider your instructions to hospitals, which should be preparing now to postpone non-urgent planned activity in order to provide a safe urgent and emergency service in keeping with the levels of staff available.' In previous strikes, there was a so-called 'derogation' process where hospitals can request striking doctors return to work if there is risk to patient safety. The BMA said that it is 'committed' to the process but not to facilitating non-urgent work. The previous strikes ended last September when resident doctor members voted to accept a Government pay deal worth 22.3% on average over two years. The 2025/26 pay deal saw resident doctors given a 4% increase plus £750 'on a consolidated basis', working out as an average rise of 5.4%. Government officials said these two increases equate to a 28.9% pay rise. But the BMA said resident doctors need 29.2% to reverse 'pay erosion' since 2008/09. The strikes are due to begin at 7am on Friday and last for five days. NHS England has been approached for comment.
The Independent
19 minutes ago
- The Independent
Dispute between Sandie Peggie and transgender doctor posed ‘no risk to patients'
A dispute between a gender critical nurse and a transgender doctor was treated as a claim and counter-claim disagreement by a manager tasked with a suspension review who found there was no risk to patients, a tribunal heard. Nurse Sandie Peggie was suspended after she complained about having to share a changing room with trans medic Dr Beth Upton at the Victoria Hospital in Kirkcaldy, Fife, on Christmas Eve 2023. She was placed on special leave and then suspended after Dr Upton made an allegation of bullying and harassment and cited concerns about 'patient care'. Ms Peggie has lodged a claim against NHS Fife and Dr Upton, citing the Equality Act 2010, including sexual harassment; harassment related to a protected belief; indirect discrimination; and victimisation. The tribunal resumed in Dundee on July 16 after an initial set of hearings in February. On Monday at the tribunal, service manager Lottie Myles said she perceived the dispute which led to Ms Peggie being suspended as a 'she said/she said' situation, and there was 'nobody who could provide evidence'. Ms Myles said she was tasked with conducting a suspension review on February 27 2024, and was told by the nurse's manager, Esther Davidson, that Ms Peggie was 'anti-trans', and 'had transphobic views because of an incident that occurred in the changing room'. She said that Ms Davidson alleged Ms Peggie had 'some gender critical beliefs, and some other beliefs which she has which may not be everybody's belief', an hour before a suspension review meeting, but Ms Myles said she was not given any documentation to examine prior to the review. During the tribunal, counsel for NHS Fife, Jane Russell KC, asked about these 'other beliefs'. Ms Myles said: 'There was views that Sandie was homophobic and there were elements of racism in her beliefs. It's hearsay. I try to disregard views which haven't been documented or there's little evidence of.' She noted that Ms Peggie referred to Dr Upton using 'male terminology', but said that she believed Ms Peggie's feelings about Dr Upton were 'circumstantial', and later challenged why allegations she branded 'hearsay' had not been documented or escalated, the tribunal heard. Ms Russell said: 'Arising out of this meeting, what was your opinion about how Sandie Peggie really felt about Dr Upton?' The witness said: 'I think Sandie probably wasn't too happy with Dr Upton but I think that was more from the incident which had happened. In summary notes, I had asked if she was to treat a patient who was transgender, would she treat them differently? 'I was reassured she said she wouldn't treat anyone trans differently; I felt that it was circumstantial.' Ms Russell asked for the witness's views on how Ms Peggie 'might deal with transgender patients' after a suspension review meeting on March 7 2024. Ms Myles said: 'I felt reassured she wouldn't treat them differently. Sandie has been a nurse for 30 years, I'm sure in that time she has dealt with transgender patients. I felt there were no safety concerns.' She said she referred to the Nursing and Midwifery Council code, including on freedom of expression, and the Equality Act 2010 which she described as a 'grey area in a lot of workplaces', and said there were 'several reasons' why she lifted the suspension, the tribunal heard. Ms Myles said: 'I wanted to be sure I wouldn't be treating either party in breach of the Equality Act. I wanted to have Dr Upton and Sandie Peggie treated fairly and equally.' She said that a meeting between herself, Ms Peggie and Royal College of Nursing rep Stuart Fraser was 'very difficult' and 'emotional' for Ms Peggie, who was determined to return to the Emergency Department rather than be moved to another department managed by Ms Myles, the tribunal heard. Ms Myles said: 'I wanted both parties to be treated fairly and equally. The situation was 'she said/ she said', we were limited on witnesses and things being documented.' The witness said that a return to work would be 'beneficial' for Ms Peggie, and that she wanted to 'make it as seamless as possible', after discussions about moving departments and moving onto dayshifts were both rejected, the tribunal heard. Giving evidence, Ms Myles said she was aware of reports of 'negative interactions', which she branded 'hearsay'. Ms Myles said: 'I actually challenged that by saying: 'Why wasn't this documented? Why wasn't it escalated?' Nobody could confirm, but I felt that was hearsay. I felt that to try to prevent any other allegations from happening having a senior team member on duty would be supportive for her.' She said it was agreed to put the pair on 'opposite shifts' and for Ms Peggie to be supervised during a phased return, describing it as a 'compromise', the tribunal heard. Ms Myles said that her involvement ceased around April 19 at the request of head of nursing Gillian Malone, and she had no role in the investigation. The tribunal continues.
Telegraph
38 minutes ago
- Telegraph
Why England can learn from Scotland after first measles death in a decade
The NHS in England could learn important lessons from Scotland after a measles death in Liverpool last week, experts say. Comparative data shows that vaccine uptake in Scotland is considerably higher than in England, with nearly 90 per cent of children fully protected against measles by age five. The difference, say experts, is most likely to be explained by the fact that access to GPs and other primary health care facilities is much better north of the border 'Everybody talks about [vaccine] hesitancy, but the main thing that's stopping uptake is access,' Dr Helen Bradford, Professor of Children's Health at University College London, told The Telegraph. 'That includes knowing what vaccine is due and when, being able to make an appointment, and actually getting to that appointment – all of which can be really difficult for some families.' News of the death of a child in Liverpool of measles comes as Britain's vaccination rates have fallen to the lowest of any G7 country, including the US. The problem appears to be being driven by the performance of the NHS in England. At least 89.2 per cent of Scottish children are fully vaccinated with the measles, mumps, and rubella (MMR) vaccine by age five, compared to just 83.9 per cent in England. At the same time, Scotland has much better access to primary care – with 76 GP's per 100,000 people, compared to just 58 per 100,000 in England. 'General practice [in England] has continually had resources withdrawn, but at the same time delivers most of the childhood vaccinations,' said Dr David Elliman, an honorary senior associate professor and medical doctor at UCL. Access, he added, was the most important issue. 'In a GP practice, most parents are happy to have their children immunised. Some may have questions, but as long as they receive clear and satisfactory answers, they're usually comfortable proceeding,' he added. During the pandemic – a time where nearly all health systems saw a noticeable decrease in routine vaccinations – Scotland's coverage of routine childhood jabs actually increased. Researchers at the University of Edinburgh found a 14.3 per cent increase in children receiving the second dose of the MMR vaccine on time during the first lockdown in Scotland compared with vaccination levels in 2019. England saw a net fall in the same period of 1.93 per cent. The researchers linked the boost to flexible working for parents – which meant they could attend vaccination appointments – and better access to mobile vaccination centres. In 2018, the Scottish Government took the decision to transfer the responsibility for delivering vaccinations from GP practices to regional health boards as part of a plan to boost uptake. While most vaccines are still administered by GPs, the shift gave health boards the flexibility to tailor services for harder-to-reach communities. Unlike in England – where families often struggle with rigid booking systems, the so-called '8am scramble' for same day appointments, and limited availability – Scotland offers vaccinations in several different settings like schools, A&E departments, and at home visits. 'We need to get away from being too rigid in what sort of settings we give the vaccine in. Traditionally it's either been a community clinic or general practice but we ought to be doing it more in the places that parents go to, and particularly children who are at high risk,' said Dr Elliman. 'That means more immunisations in hospital settings and in neighbourhoods,' he added. Scotland's better vaccination rates appear to be positively influencing outcomes. So far this year, England has recorded 529 measles cases, while Scotland has had just 27. In 2024, those numbers were even more dramatic: 2,911 cases were recorded in England, compared to just 24 in Scotland. While population size partly explains the disparity – England's population is more than eleven times larger than Scotland's – it doesn't account for an almost 120-fold difference in infection rates, say experts. Only last week, the health secretary Wes Streeting acknowledged the need for better access to primary health care in England. Under the government's new NHS 10-year plan, he committed to rolling out 'neighbourhood health services' to try and 'end the 8am scramble and make it easier to see your GP,' referencing the country's maddening and archaic GP booking system. The document also includes a plan to boost vaccine uptake by allowing nurses and midwives that carry out home visits to administer vaccines in England. Yet it is unclear when the new measures will come into force: England currently faces a 5,000 shortfall in the number of health visitors needed to provide the mandated four at-home visits required for every child in the country under school age. Scotland outcompetes England in this area, too. About 90 per cent of Scottish children receive at least their first four scheduled reviews, compared to just short of 65 per cent in parts of England, including London. 'These are the public health nurses that have contact with all young families with young children, often the first port of call, the first place that parents will ask questions about immunisation. The numbers [in England] have gone down dramatically, which for those people who have got questions means there isn't always somebody obvious to ask,' said Dr Bradford.
